AI Agents will Transform MedTech

When Leo was born in 2023, I jokingly wondered if he'd ever have to write an essay without AI's help. Just two years later, LLMs have moved way beyond word processing; they've changed how I think, work, and solve problems for our customers. I have never been more excited about the impact a new technology will have on humanity.

At AcuityMD we've been bullish on AI since the launch of our very first entity resolution algorithm. But we've been blown away by how quickly agentic AI, AI that takes action proactively, is reshaping how we can build new products. Over the past few months, I've been experimenting intensely, prototyping autonomous agents tailored specifically to MedTech’s complex workflows:

• Agents that proactively identify commercial whitespace, uncovering opportunities before companies (and their competitors) even realize the gap exists.
• Intelligent workflows that dynamically map surgeon preferences and conduct autonomous market research, rapidly synthesizing insights and identifying strategic opportunities.
• Autonomous prototypes that draft tailored messages to healthcare executives, dramatically shortening our path from insight to action.

A few weekends ago, I went a step further: I tasked an AI agent to analyze MedTech's gaps in R&D and craft strategic recommendations. It didn't just deliver; it went beyond my prompts, autonomously proposing actionable next steps, suggesting data analyses and integrations, prototyping a newsletter, and even drafting a potential patent filing for a new innovation we brainstormed.

This wasn't just efficiency; it was taking initiative. And that’s the game changer.

At AcuityMD, we’re leveraging these breakthroughs to fundamentally rethink our roadmap for MedTech. Imagine your sales and marketing teams empowered with agents that autonomously:

• Identify and prioritize high-value surgeons and hospitals.
• Generate hyper-personalized messaging and commercial strategies at scale.
• Automate away time-consuming administrative tasks like CRM entry, freeing your people to focus on building relationships and driving real growth.

We see AI as a multiplier aligned with AcuityMD’s core value: Be a compounding force. AI agents aren’t just tools; they're catalysts enabling every member of your team to be 10x more productive, strategic, and impactful.

The message for MedTech leaders is clear: The future is already here. MedTech companies that embrace AI across both product development and commercial excellence will separate themselves from the competition and bring more innovative treatments to patients faster. The teams adopting AI now will set the pace, dramatically outcompeting those who hesitate.

The agentic AI wave has arrived in MedTech. At AcuityMD, we're not just riding it; we're pioneering what’s next. Our product vision for the MedTech industry continues to sail into new waters, lifted by the tailwinds of a technology that improves and adapts every day.

Join our mission to accelerate adoption of cutting edge medical technology!

‍

Mike Monovoukas

CEO and Co-founder

AcuityMD

‍